All posts
Published
June 23, 2025

Ebook: 2023 Healthcare Trends in Emerging Markets A Look Ahead

The Speyside Healthcare team has published its 2023 outlook, analyzing key trends shaping high-growth and emerging markets post-pandemic. Our analysis focuses on the urgent need for impactful, locally-rooted partnerships to address challenges from affordability and prevention to regulatory harmonization and AI integration. This report provides the critical insights global healthcare companies need to build lasting value and secure market access.

The Speyside Healthcare team has published its 2023 outlook, analyzing key trends shaping high-growth and emerging markets post-pandemic. Our analysis focuses on the urgent need for impactful, locally-rooted partnerships to address challenges from affordability and prevention to regulatory harmonization and AI integration. This report provides the critical insights global healthcare companies need to build lasting value and secure market access.

After being hit the hardest by the pandemic, many emerging market stakeholders are now looking for  impactful, long-term partnerships with global healthcare companies that add real value to local populations. Those companies that step-up and structure meaningful partnerships will reap benefits over time in terms of reputation, relationships and market access. However, any such partnerships need to be rooted in a deep understanding of the local environment.

At Speyside Group we have analyzed the landscape for healthcare in emerging markets and identified some trends that will shape healthcare systems in the
near term. This report contains a brief analysis of the main trends and opportunities that 2023 will bring in the  following areas:

  • The challenge of healthcare  affordability amid increasing healthcare costs.
  • The shift towards prevention focused healthcare systems.
  • Market access in the context of  regulatory harmonization and reliance.
  • Impactful collaboration to contribute  to enhanced innovation capacity across the globe.
  • Lasting changes in healthcare dynamics and patients after the pandemic.
  • Integration of AI, technology, and data analysis for healthcare decisions.
  • Climate Change & Healthcare.

Download our ebook here: Speyside 2023 Emerging Markets Healthcare Outlook

Conclusion

In 2023, healthcare systems in emerging markets will be shaped by rising costs, a shift toward prevention, increased use of technology, and the need for meaningful partnerships. Companies that go beyond transactional relationships and invest in deep, locally informed collaborations will position themselves as strategic allies. Innovation, regulatory harmonization, and climate change response will be key to building more resilient and equitable healthcare systems in the near future.

Recent News

View All News
APAC

Navigating Indonesia’s Shifting Political and Investment Landscape

Indonesia’s investment landscape is becoming more state-directed and politically dynamic. While sectors such as mining and energy face greater regulatory scrutiny, new areas of growth, from data centers to downstream industries, continue to attract investment. For businesses, understanding where power sits and building credible, long-term relationships is becoming increasingly important.
Read post
Public Affairs

How Should Governments and Investors Read the EU’s 2028–2034 Budget Negotiation?

Speyside Group provides an analytical assessment of the EU's 2028-2034 Multiannual Financial Framework negotiation, examining the institutional redesign of EU spending priorities, the proposed National and Regional Partnership Plans, and the strategic competition for funding between cohesion, defense, and competitiveness objectives that will shape corporate access to EU capital through 2034.
Read post
Technology

EU AI Act: What Companies Need to Know for December 2026 and What’s Delayed

Speyside Group provides a practical explanation of what the EU AI Act will require from companies on December 2nd, 2026, following the postponement of the main high-risk obligations to 2027. While the delay gives businesses more time to prepare for the most demanding compliance requirements, it does not represent a broader pause to the AI Act. The December 2nd, 2026 milestone remains relevant, bringing the end of a specific transition period and two additional prohibited AI practices into scope.
Read post